Peer-reviewed Publications

For the most up to date list of publications, check out my Google Scholar page.

Rieken M, Djajadiningrat RS, Kluth LA, Favaretto RL, Xylinas E, Guimaraes GC, Soares FA, Kent M, Sjoberg DD, Horenblas S and others (2014). “Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis.” European urology, 66(5), pp. 811-814.

Silberstein JL, Poon SA, Sjoberg DD, Maschino AC, Vickers AJ, Bernie A, Konety BR, Kevin Kelly W and Eastham JA (2015). “Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer.” BJU international, 116(1), pp. 50-56.

Bochner BH, Sjoberg DD and Laudone VP (2014). “A randomized trial of robot-assisted laparoscopic radical cystectomy.” New England Journal of Medicine, 371(4), pp. 389-390.

Kim PH, Sukhu R, Cordon BH, Sfakianos JP, Sjoberg DD, Hakimi AA, Dalbagni G, Lin O and Herr HW (2014). “Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy.” BJU international, 114(3), pp. 354-359.

Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, Olden M, Pessin H, Lichtenthal W, Sjoberg D and others (2012). “Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer.” Journal of Clinical Oncology, 30(12), pp. 1304.

Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Björk T, Gerdtsson A, Manjer J, Nilsson PM, Dahlin A, Bjartell A and others (2013). “Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study.” Bmj, 346, pp. f2023.

Tarin TV, Power NE, Ehdaie B, Sfakianos JP, Silberstein JL, Savage CJ, Sjoberg D, Dalbagni G and Bochner BH (2012). “Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.” European urology, 61(5), pp. 1025-1030.

Cassileth BR, Van Zee KJ, Yeung KS, Coleton MI, Cohen S, Chan YH, Vickers AJ, Sjoberg DD and Hudis CA (2013). “Acupuncture in the treatment of upper-limb lymphedema.” Cancer, 119(13), pp. 2455-2461.

Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee RK, Hansen J, Cha EK, Raman JD, Remzi M and others (2012). “Risk of cancer-specific mortality following recurrence after radical nephroureterectomy.” Annals of surgical oncology, 19(13), pp. 4337-4344.

Margulis V, Shariat SF, Rapoport Y, Rink M, Sjoberg DD, Tannir NM, Abel EJ, Culp SH, Tamboli P and Wood CG (2013). “Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.” European urology, 63(5), pp. 947-952.

Vickers AJ, Sjoberg D, Basch E, Sculli F, Shouery M, Laudone V, Touijer K, Eastham J and Scardino PT (2012). “How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy.” European urology, 61(2), pp. 284-289.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT and Eastham JA (2014). “Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.” European urology, 65(1), pp. 20-25.

Rink M, Lee DJ, Kent M, Xylinas E, Fritsche H, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A and others (2013). “Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.” BJU international, 111(3b).

Carlsson SV, Tafe LJ, Chade DC, Sjoberg DD, Passoni N, Shariat SF, Eastham J, Scardino PT, Fine SW and Touijer KA (2013). “Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.” The Journal of urology, 189(4), pp. 1314-1319.

Deng G, Chan Y, Sjoberg D, Vickers A, Yeung KS, Kris M, Straus D and Cassileth B (2013). “Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial.” Supportive Care in Cancer, 21(6), pp. 1735-1741.

Bancroft EK, Page EC, Castro E, Lilja H, Vickers A, Sjoberg D, Assel M, Foster CS, Mitchell G, Drew K and others (2014). “Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.” European urology, 66(3), pp. 489-499.

Carlsson S, Assel M, Sjoberg D, Ulmert D, Hugosson J, Lilja H and Vickers A (2014). “Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.” Bmj, 348, pp. g2296.

Sankin A, Sfakianos JP, Schiff J, Sjoberg D and Coleman JA (2012). “Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate.” Urology, 80(2), pp. 343-346.

Christensson A, Savage C, Sjoberg DD, Cronin AM, Frank O’Brien M, Lowrance W, Nilsson PM, Vickers AJ, Russo P and Lilja H (2013). “Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years.” International journal of cancer, 133(6), pp. 1452-1458.

Vickers AJ, Sjoberg DD, Ulmert D, Vertosick E, Roobol MJ, Thompson I, Heijnsdijk EA, De Koning H, Atoria-Swartz C, Scardino PT and others (2014). “Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.” BMC medicine, 12(1), pp. 26.

Braun K, Ahallal Y, Sjoberg DD, Ghoneim T, Esteban MD, Mulhall J, Vickers A, Eastham J, Scardino PT and Touijer KA (2014). “Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer.” The Journal of urology, 191(3), pp. 744-749.

Deng G, Wong WD, Guillem J, Chan Y, Affuso T, Yeung KS, Coleton M, Sjoberg D, Vickers A and Cassileth B (2013). “A phase II, randomized, controlled trial of acupuncture for reduction of postcolectomy ileus.” Annals of surgical oncology, 20(4), pp. 1164-1169.

Carlsson SV, Peltola MT, Sjoberg D, Schröder FH, Hugosson J, Pettersson K, Scardino PT, Vickers AJ, Lilja H and Roobol MJ (2013). “Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?” BJU international, 112(5), pp. 602-609.

Vickers AJ, Sjoberg DD, Ankerst DP, Tangen CM, Goodman PJ and Thompson IM (2013). “The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome.” Cancer, 119(16), pp. 3007-3011.

Hakimi AA, Chen L, Kim PH, Sjoberg D, Glickman L, Walker MR and Russo P (2013). “The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma.” Canadian Urological Association Journal, 7(11-12), pp. E687.

Carlsson S, Berglund A, Sjoberg D, Khatami A, Stranne J, Bergdahl S, Lodding P, Aus G, Vickers A and Hugosson J (2014). “Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.” BMC urology, 14(1), pp. 25.

Spaliviero M, Dalbagni G, Bochner BH, Poon BY, Huang H, Al-Ahmadie HA, Donahue TF, Taylor JM, Meeks JJ, Sjoberg DD and others (2014). “Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder.” The Journal of urology, 192(3), pp. 702-707.

Silberstein JL, Sprenkle PC, Su D, Power NE, Tarin TV, Ezell P, Sjoberg DD, Feifer A, Fleisher M, Russo P and others (2013). “Neutrophil gelatinase-associated lipocalin (NGAL) levels in response to unilateral renal ischaemia in a novel pilot two-kidney porcine model.” BJU international, 112(4), pp. 517-525.

Forsberg JA, Sjoberg D, Chen Q, Vickers A and Healey JH (2013). “Treating metastatic disease: which survival model is best suited for the clinic?” Clinical Orthopaedics and Related Research®, 471(3), pp. 843-850.

Musser JE, Assel M, Guglielmetti GB, Pathak P, Silberstein JL, Sjoberg DD, Bernstein M and Laudone VP (2014). “Impact of routine use of surgical drains on incidence of complications with robot-assisted radical prostatectomy.” Journal of endourology, 28(11), pp. 1333-1337.

Silberstein JL, Poon SA, Sjoberg D, Vickers AJ, Bernie A, Konety BR, Kelly WK and Eastham JA (2014). “Long-term oncologic outcomes of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk prostate cancer.”

Gondo T, Poon BY, Matsumoto K, Bernstein M, Sjoberg DD and Eastham JA (2015). “Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3+ 4 prostate cancer.” BJU international, 115(1), pp. 81-86.

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J and Russo P (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191(5), pp. 1225-1230.

Tarin T, Feifer A, Kimm S, Chen L, Sjoberg D, Coleman J and Russo P (2014). “Impact of a common clinical pathway on length of hospital stay in patients undergoing open and minimally invasive kidney surgery.” The Journal of urology, 191(5), pp. 1225-1230.

Hochberg-Garrett H, Hoelscher D, Sharma S and Sjoberg D (2009). “The Skip to Breakfast Project: Development, Implementation, and Evaluation of an Intervention to Increase Healthful Breakfast Consumption among Fifth Grade Students and Their Families.” Journal of the American Dietetic Association, 109(9), pp. A81.

Sjoberg DD (2015). “Toward a Smarter Prostate Cancer Screening Program.” European urology, 68(4), pp. 598-599.

Hong SK, Poon BY, Sjoberg DD, Scardino PT and Eastham JA (2014). “Prostate size and adverse pathologic features in men undergoing radical prostatectomy.” Urology, 84(1), pp. 153-157.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT and Eastham JA (2014). “Reply to Michael Froehner, Rainer Koch, and Manfred P. Wirth’s Letter to the Editor re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term Outcomes of Patients with Lymph Node Metastasis Treated with Radical Prostatectomy Without Adjuvant Androgen-deprivation Therapy. Eur Urol 2014; 65: 20-5.” European urology, 65(2), pp. e25-e26.

Sankin A, Kent M, Sjoberg D and Scardino PT (2014). “Does tumor grade affect the relationship between preoperative prostate-specific antigen (PSA) and biochemical recurrence (BCR)?”

Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA and Amar D (2014). “Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study.” Canadian Journal of Anesthesia/Journal canadien d’anesthésie, 61(12), pp. 1068-1074.

Musser JE, Assel M, Mashni JW, Sjoberg DD and Russo P (2014). “Adult prostate sarcoma: the Memorial Sloan Kettering experience.” Urology, 84(3), pp. 624-628.

Spaliviero M, Poon BY, Aras O, Di Paolo PL, Guglielmetti GB, Coleman CZ, Karlo CA, Bernstein ML, Sjoberg DD, Russo P and others (2015). “Interobserver variability of RENAL, PADUA, and centrality index nephrometry score systems.” World journal of urology, 33(6), pp. 853-858.

Fossati N, Sjoberg DD, Capitanio U, Gandaglia G, Larcher A, Nini A, Mirone V, Vickers AJ, Montorsi F and Briganti A (2015). “Extended pelvic lymph node dissection in patients with prostate cancer previously treated with surgery for lower urinary tract symptoms.” BJU international, 116(3), pp. 366-372.

Mano R, Vertosick E, Sankin AI, Chevinsky MS, Larish Y, Jakubowski CD, Hötker AM, Hakimi AA, Sjoberg DD, Akin O and others (2015). “Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.” The Journal of urology, 193(3), pp. 776-782.

Hong SK, Vertosick E, Sjoberg DD, Scardino PT and Eastham JA (2014). “Insignificant disease among men with intermediate-risk prostate cancer.” World journal of urology, 32(6), pp. 1417-1421.

Matignon M, Ding R, Dadhania DM, Mueller FB, Hartono C, Snopkowski C, Li C, Lee JR, Sjoberg D, Seshan SV and others (2014). “Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction.” Journal of the American Society of Nephrology, pp. ASN-2013080900.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I and others (2015). “A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.” European urology, 68(3), pp. 464-470.

Moses KA, Chen LY, Sjoberg DD, Bernstein M and Touijer KA (2014). “Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.” BMC urology, 14(1), pp. 98.

Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Paz GEK, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC and others (2015). “Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial.” European urology, 67(6), pp. 1042-1050.

Vickers AJ and Sjoberg DD (2015). “Guidelines for reporting of statistics in European Urology.” European urology, 67(2), pp. 181-187.

Vickers AJ and Sjoberg DD (2015). “Decision analysis of dutasteride use for patients with negative prostate biopsy.” Urology, 85(2), pp. 337-342.

Bazzi WM, Sjoberg DD, Feuerstein MA, Maschino A, Verma S, Bernstein M, O’Brien MF, Jang T, Lowrance W, Motzer RJ and others (2015). “Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.” The Journal of urology, 193(6), pp. 1911-1917.

Wesa KM, Segal NH, Cronin AM, Sjoberg DD, Jacobs GN, Coleton MI, Fleisher M, Dnistrian AM, Saltz LB and Cassileth BR (2015). “Serum 25-hydroxy vitamin D and survival in advanced colorectal cancer: a retrospective analysis.” Nutrition and cancer, 67(3), pp. 424-430.

Stattin P, Vickers AJ, Sjoberg DD, Johansson R, Granfors T, Johansson M, Pettersson K, Scardino PT, Hallmans G and Lilja H (2015). “Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case-control study.” European urology, 68(2), pp. 207-213.

Selby LV, Vertosick EA, Sjoberg DD, Schattner MA, Janjigian YY, Brennan MF, Coit DG and Strong VE (2015). “Morbidity after total gastrectomy: analysis of 238 patients.” Journal of the American College of Surgeons, 220(5), pp. 863-871.

Musser JE, Assel MJ, Meeks JJ, Sjoberg DD, Vickers AJ, Coleman JA, Eastham JA, Parra RO, Scardino PT, Touijer KA and others (2015). “Ambulatory Extended Recovery: Safely Transitioning to Overnight Observation for Minimally Invasive Prostatectomy.” Urology Practice, 2(3), pp. 121-125.

Selby LV, Sjoberg DD, Cassella D, Sovel M, Weiser MR, Sepkowitz K, Jones DR and Strong VE (2015). “Comparing surgical infections in National Surgical Quality Improvement Project and an Institutional Database.” Journal of Surgical Research, 196(2), pp. 416-420.

Fossati N, Passoni NM, Moschini M, Gandaglia G, Larcher A, Freschi M, Guazzoni G, Sjoberg DD, Vickers AJ, Montorsi F and others (2016). “Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades.” BJU international, 117(5), pp. 740-747.

Mano R, Kent M, Larish Y, Winer AG, Chevinsky MS, Hakimi AA, Sternberg IA, Sjoberg DD and Russo P (2015). “Partial and radical nephrectomy for unilateral synchronous multifocal renal cortical tumors.” Urology, 85(6), pp. 1404-1410.

Sjoberg DD, Bryant RJ, Vickers AJ, Robinson MC, Kumar R, Marsden L, Davis M, Scardino PT, Donovan J, Neal DE and others (2015). “Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study.” JNCI: Journal of the National Cancer Institute, 107(7).

Imnadze M, Sjoberg DD and Vickers AJ (2016). “Adverse pathologic features at radical prostatectomy: effect of preoperative risk on oncologic outcomes.” European urology, 69(1), pp. 143-148.

Ehdaie B, Poon BY, Sjoberg DD, Recabal P, Laudone V, Touijer K, Eastham J and Scardino PT (2016). “Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.” BJU international, 118(4), pp. 535-540.

Anderson CB, Tin AL, Sjoberg DD, Mulhall JP, Sandhu J, Touijer K, Laudone VP, Eastham JA, Scardino PT and Ehdaie B (2016). “Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.” BJU international, 117(6B).

Sankin A, Tin AL, Mano R, Chevinsky M, Jakubowski C, Sfakianos JP, Cha EK, Yee A, Friedman FM, Sjoberg DD and others (2016). “Impact of ureteroscopy before nephroureterectomy for upper tract urothelial carcinoma on oncologic outcomes.” Urology, 94, pp. 148-153.

Cesarini M, Collins G, Ronnblom A, Santos A, Sjoberg D, Parkes M, Keshav S and Travis S (2015). “Predicting the risk of acute severe colitis (ASC) at diagnosis of Ulcerative Colitis (UC): external validation.” Journal of Crohn’s and Colitis, 9(suppl 1), pp. S195-S195.

Ghoneim TP, Sjoberg DD, Lowrance W, Shariat SF, Savage C, Bernstein M and Russo P (2015). “Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics.” World journal of urology, 33(12), pp. 2023-2029.

Braun K, Sjoberg DD, Vickers AJ, Lilja H and Bjartell AS (2016). “A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort.” European urology, 69(3), pp. 505-511.

Fossati N, Larcher A, Gadda GM, Sjoberg DD, Mistretta FA, Dell’Oglio P, Lista G, Carenzi C, Lughezzani G, Lazzeri M and others (2015). “Minimally invasive partial nephrectomy versus laparoscopic cryoablation for patients newly diagnosed with a single small renal mass.” European urology focus, 1(1), pp. 66-72.

Chevinsky M, Imnadze M, Sankin A, Winer A, Mano R, Jakubowski C, Mashni J, Sjoberg DD, Chen Y, Tickoo SK and others (2015). “Pathological stage T3a significantly increases disease recurrence across all tumor sizes in renal cell carcinoma.” The Journal of urology, 194(2), pp. 310-315.

Anderson CB, Sternberg IA, Karen-Paz G, Kim PH, Sjoberg D, Vargas HA, Touijer K, Eastham JA and Ehdaie B (2015). “Age is associated with upgrading at confirmatory biopsy among men with prostate cancer treated with active surveillance.” The Journal of urology, 194(6), pp. 1607-1611.

Bazzi WM, Sjoberg DD, Grasso AA, Bernstein M, Parra R and Coleman JA (2015). “Predicting length of stay after robotic partial nephrectomy.” International urology and nephrology, 47(8), pp. 1321-1325.

Epstein JI, Zelefsky MJ, Sjoberg DD, Nelson JB, Egevad L, Magi-Galluzzi C, Vickers AJ, Parwani AV, Reuter VE, Fine SW and others (2016). “A contemporary prostate cancer grading system: a validated alternative to the Gleason score.” European urology, 69(3), pp. 428-435.

Nguyen DP, Vilaseca A, Vertosick EA, Corradi RB, Touijer KA, Benfante NE, Sjoberg DD and Russo P (2016). “Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically.” World journal of urology, 34(4), pp. 539-544.

Bazzi WM, Chen LY, Cordon BH, Mashni J, Sjoberg DD, Bernstein M and Russo P (2015). “Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.” International urology and nephrology, 47(9), pp. 1499-1502.

Lee JK, Assel M, Thong AE, Sjoberg DD, Mulhall JP, Sandhu J, Vickers AJ and Ehdaie B (2015). “Unexpected long-term improvements in urinary and erectile function in a large cohort of men with self-reported outcomes following radical prostatectomy.” European urology, 68(5), pp. 899-905.

Spaliviero M, Poon BY, Karlo CA, Guglielmetti GB, Di Paolo PL, Corradi RB, Martin-Malburet AG, Campos-Juanatey F, Escudero-Fontano E, Sjoberg DD and others (2016). “An arterial based complexity (ABC) scoring system to assess the morbidity profile of partial nephrectomy.” European urology, 69(1), pp. 72-79.

Bondarik A and Sjöberg D (2015). “Implementation of UC-EBG structure for 60 GHz gridded parasitic patch stacked microstrip antenna.” In Antennas and Propagation (EuCAP), 2015 9th European Conference on, pp. 1-5. IEEE.

Feuerstein MA, Musser JE, Kent M, Chevinsky M, Cha EK, Kimm S, Hilton WM, Sjoberg DD, Donahue TF, Vargas HA and others (2016). “Low yield of surveillance imaging after surgery for T1 kidney cancer.” World journal of urology, 34(7), pp. 949-953.

Liu NW, Wren JD, Vertosick E, Lee JK, Power NE, Benfante NE, Kimm SY, Bains MS, Sjoberg DD, Russo P and others (2016). “The prognostic impact of a positive vascular margin on pT3 clear cell renal cell carcinoma.” The Journal of urology, 195(2), pp. 264-269.

Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, Scardino PT, Soff GA, Fabbri N, Sepkowitz K and others (2016). “Preoperative chemoprophylaxis is safe in major oncology operations and effective at preventing venous thromboembolism.” Journal of the American College of Surgeons, 222(2), pp. 129-137.

Punnen S, Nahar B, Prakash NS, Sjoberg DD, Zappala SM and Parekh DJ (2017). “The 4Kscore predicts the grade and stage of prostate cancer in the radical prostatectomy specimen: results from a multi-institutional prospective trial.” European urology focus, 3(1), pp. 94-99.

Mano R, Vertosick EA, Hakimi AA, Sternberg IA, Sjoberg DD, Bernstein M, Dalbagni G, Coleman JA and Russo P (2016). “The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4 cm.” In Urologic Oncology: Seminars and Original Investigations, volume 34 number 5, pp. 239-e1. Elsevier.

Lilja H, Vickers AJ, Sjoberg D, Johansson R, Granfors T, Johansson M, Pettersson K, Scardino PT, Hallmans G and Stattin P (2014). “Improving the specificity of prostate cancer screening for early detection of lethal disease.”

Recabal P, Assel M, Sjoberg DD, Lee D, Laudone VP, Touijer K, Eastham JA, Vargas HA, Coleman J and Ehdaie B (2016). “The efficacy of multiparametric magnetic resonance imaging and magnetic resonance imaging targeted biopsy in risk classification for patients with prostate cancer on active surveillance.” The Journal of urology, 196(2), pp. 374-381.

Recabal P, Assel M, Musser JE, Caras RJ, Sjoberg DD, Coleman JA, Mulhall JP, Parra RO, Scardino PT, Touijer K and others (2016). “Erectile function recovery after radical prostatectomy in men with high risk features.” The Journal of urology, 196(2), pp. 507-513.

Nguyen DP, Vertosick EA, Corradi RB, Vilaseca A, Benfante NE, Touijer KA, Sjoberg DD and Russo P (2016). “Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.” In Urologic Oncology: Seminars and Original Investigations, volume 34 number 6, pp. 259-e1. Elsevier.

Bazzi WM, Tin AL, Sjoberg DD, Bernstein M and Russo P (2016). “The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma.” The Canadian journal of urology, 23(1), pp. 8151.

Nahar B, Punnen S, Sjoberg D, Zappala SM and Parekh D (2016). “The 4Kscore to predict the grade and stage of prostate cancer in the radical prostatectomy specimen: Results from a multi-institutional prospective trial.”

Nahar B, Punnen S, Zappala SM, Sjoberg D and Parekh D (2016). “Among men with low-grade prostate cancer on prostate biopsy, the 4Kscore to predict prostate cancer aggressiveness at prostatectomy.”

Anderson C, Weber R, Patel D, Lowrance W, Mellis A, Cookson M, Lang M, Barocas D, Chang S, Newberger E and others (2016). “A 10-item checklist improves reporting of critical procedural elements during transurethral resection of bladder tumor.” The Journal of urology, 196(4), pp. 1014-1020.

Vilaseca A, Nguyen DP, Vertosick EA, Corradi RB, Musquera M, Pérez M, Fossati N, Sjoberg DD, Farré R, Almendros I and others (2017). “Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically.” World journal of urology, 35(1), pp. 51-56.

Gugliemetti G, Sukhu R, Baenas MC, Meeks J, Sjoberg D, Eastham J, Scardino P and Touijer K (2016). “Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.” Actas Urológicas Españolas (English Edition), 40(7), pp. 434-439.

Preston MA, Batista JL, Wilson KM, Carlsson SV, Gerke T, Sjoberg DD, Dahl DM, Sesso HD, Feldman AS, Gann PH and others (2016). “Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.” Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 34(23), pp. 2705-2711.

Jakubowski CD, Vertosick EA, Untch BR, Sjoberg D, Wei E, Palmer FL, Patel SG, Downey RJ, Strong VE and Russo P (2016). “Complete metastasectomy for renal cell carcinoma: comparison of five solid organ sites.” Journal of surgical oncology, 114(3), pp. 375-379.

Manley BJ, Tennenbaum DM, Vertosick EA, Hsieh JJ, Sjoberg DD, Assel M, Benfante NE, Strope SA, Kim E, Casuscelli J and others (2017). “The difficulty in selecting patients for cytoreductive nephrectomy: an evaluation of previously described predictive models.” In Urologic Oncology: Seminars and Original Investigations, volume 35 number 1, pp. 35-e1. Elsevier.

Chen R, Sjoberg DD, Huang Y, Xie L, Zhou L, He D, Vickers AJ, Sun Y, Ding Q, Wei Q and others (2017). “Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts.” The Journal of urology, 197(1), pp. 90-96.

Vickers A, Vertosick EA, Sjoberg DD, Roobol MJ, Hamdy F, Neal D, Bjartell A, Hugosson J, Donovan JL, Villers A and others (2017). “Properties of the 4-kallikrein panel outside the diagnostic gray zone: meta-analysis of patients with positive digital rectal examination or prostate specific antigen 10 ng/ml and above.” The Journal of urology, 197(3), pp. 607-613.

Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ and Lilja H (2017). “Detection of high grade prostate cancer among PLCO participants using a prespecified 4-kallikrein marker panel.” The Journal of urology, 197(4), pp. 1041-1047.

Liu N, Wren J, Vertosick E, Lee J, Power N, Benfante N, Kimm S, Bains M, Sjoberg D, Russo P and others (2016). “Re: The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.” J Urol, 195, pp. 568e573.

Dong Y, Vickers AJ, Sjoberg D, Scardino PT and Lilja H (2016). “Compositions and methods for active surveillance of prostate cancer.” US Patent App. 15/143,329.

O’Shaughnessy MJ, McBride SM, Vargas HA, Touijer KA, Morris MJ, Danila DC, Laudone VP, Bochner BH, Sheinfeld J, Dayan ES and others (2017). “A pilot study of a multimodal treatment paradigm to accelerate drug evaluations in early-stage metastatic prostate cancer.” Urology, 102, pp. 164-172.

Nguyen D, Kent M, Vilaseca A, Corradi R, Fossati N, Sjoberg D, Benfante N, Eastham J, Scardino P and Touijer K (2017). “Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy.” Prostate cancer and prostatic diseases, 20(1), pp. 105.

Lee DJ, Recabal P, Sjoberg DD, Thong A, Lee JK, Eastham JA, Scardino PT, Vargas HA, Coleman J and Ehdaie B (2016). “Comparative effectiveness of targeted prostate biopsy using magnetic resonance imaging ultrasound fusion software and visual targeting: a prospective study.” The Journal of urology, 196(3), pp. 697-702.

Winer AG, Vertosick EA, Ghanaat M, Corradi RB, Carlsson S, Sjoberg DD, Sankin AI, Sfakianos JP, Cha EK, Dalbagni G and others (2017). “Prognostic value of lymph node yield during nephroureterectomy for upper tract urothelial carcinoma.” In Urologic Oncology: Seminars and Original Investigations, volume 35 number 4, pp. 151-e9. Elsevier.

Melchart D and Dörfler W (2013). “Acupuncture for postoperative gastrointestinal dysfunction: to treat or not to treat-is it a matter of covered eyes?” Focus on Alternative and Complementary Therapies, 18(4), pp. 201-202.

Rosenberger LH, Weber R, Sjoberg D, Vickers AJ, Mangino DA, Morrow M and Pilewskie ML (2017). “Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral.” Breast cancer research and treatment, 162(2), pp. 275-282.

Rink M, Sjoberg D, Comploj E, Margulis V, Xylinas E, Lee R, Hansen J, Cha E, Raman J, Remzi M and others (2012). “Time to Disease Recurrence is a Predictor of Cancer-Specific Mortality After Radical Nephroureterectomy.” In UROLOGY, volume 80 number 3, pp. S332-S332. ELSEVIER SCIENCE INC 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA.

Gustafsson M, Vakili I, Bayer SE, Sjoberg D and Larsson C (2011). “Optical theorem and forward scattering sum rule for periodic structures.” identity, 12, pp. 14.

Spaliviero M, Power N, Murray K, Sjoberg D, Benfante N, Bernstein M, Wren J, Russo P and Coleman J (2017). “Phase 3 randomized trial of intravenous mannitol versus placebo prior to renal ischemia during partial nephrectomy: Impact on renal functional outcomes.” European Urology Supplements, 16(3), pp. e369-e370.

Sjoberg D, Vickers A, Assel M, Dahlin A, Carlsson S, Poon B, Ulmert D and Lilja H (2017). “Risk of prostate-cancer death at 20 years stratified by midlife PSA and a panel of four kallikrein markers from a representative cohort of 11,506 healthy unscreened men aged 45-74.” European Urology Supplements, 16(3), pp. e418-e419.

Dalbagni G, Benfante N, Sjoberg DD, Bochner BH, Machele Donat S, Herr HW, Mc Coy AS, Fahrner AJ, Retinger C, Rosenberg JE and others (2017). “Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063).” Bladder Cancer, 3(2), pp. 113-119.

Dong Y, Vickers AJ, Sjoberg D, Scardino PT and Lilja H (2017). “Compositions and methods for active surveillance of prostate cancer.” US Patent App. 15/143,345.

Zappala SM, Dong Y, Linder V, Reeve M, Sjoberg DD, Mathur V, Roberts R, Okrongly D, Newmark J, Sant G and others (2017). “The 4Kscore blood test accurately identifies men with aggressive prostate cancer prior to prostate biopsy with or without DRE information.” International journal of clinical practice, 71(6).

Pietzak EJ, Assel M, Tennenbaum DM, Becerra M, Feldman DR, Bajorin DF, Motzer RJ, Bosl GJ, Carver BS, Sjoberg D and others (2016). “The role for resection of post-chemotherapy residual liver masses in the management of non-seminomatous germ cell tumor.”

O’Shaughnessy M, Eastham JA, Bochner BH, Laudone VP, Carver BS, Sjoberg D, Scardino PT, Scher HI and Touijer KA (2015). “Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients.”

Mooney K, Berry DL, Whisenant M and Sjoberg D (2017). “Improving Cancer Care Through the Patient Experience: How to Use Patient-Reported Outcomes in Clinical Practice.” In American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, volume 37, pp. 695-704.

Corradi RB, Vertosick EA, Nguyen DP, Vilaseca A, Sjoberg DD, Benfante N, Nogueira LN, Spaliviero M, Touijer KA, Russo P and others (2017). “Nephrometry scores and perioperative outcomes following robotic partial nephrectomy.” International braz j urol, 43(6), pp. 1075-1083.

Mally AD, Tin AL, Lee JK, Satasivam P, Cha EK, Donat SM, Herr HW, Bochner BH, Sjoberg DD and Dalbagni G (2018). “Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder.” Clinical genitourinary cancer, 16(1), pp. e23-e27.

Bagrodia A, Sukhu R, Winer AG, Levy E, Vacchio M, Lee B, Pietzak EJ, Donahue TF, Cha E, Iyer G and others (2018). “Incidence and effect of thromboembolic events in radical cystectomy patients undergoing preoperative chemotherapy for muscle-invasive bladder cancer.” Clinical genitourinary cancer, 16(1), pp. e113-e120.

Spaliviero M, Power NE, Murray KS, Sjoberg DD, Benfante NE, Bernstein ML, Wren J, Russo P and Coleman JA (2018). “Intravenous mannitol versus placebo during partial nephrectomy in patients with normal kidney function: a double-blind, clinically-integrated, randomized trial.” European urology, 73(1), pp. 53-59.

Polland A, Vertosick EA, Sjoberg DD, Stearns GL, Leddy LS, Kollmeier MA and Sandhu JS (2017). “Preoperative symptoms predict continence after post-radiation transurethral resection of prostate.” The Canadian journal of urology, 24(4), pp. 8903-8909.

Takeda T, Tin AL, Corradi RB, Mamoor M, Benfante NE, Sjoberg DD, Scardino PT, Eastham JA, Fine SW and Touijer KA (2018). “Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens.” European urology, 73(4), pp. 488-490.

Lee JK, Sjoberg DD, Miller MI, Vickers AJ, Mulhall JP and Ehdaie B (2018). “Improved recovery of erectile function in younger men after radical prostatectomy: does it justify immediate surgery in low-risk patients?” European urology, 73(1), pp. 33-37.

Audenet F, Vertosick EA, Fine SW, Sjoberg DD, Vickers AJ, Reuter VE, Eastham JA, Scardino PT and Touijer KA (2017). “Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.” The Journal of urology.

Thong AE, Poon BY, Lee JK, Vertosick E, Sjoberg DD, Vickers AJ and Ehdaie B (2018). “Concordance between patient-reported and physician-reported sexual function after radical prostatectomy.” In Urologic Oncology: Seminars and Original Investigations, volume 36 number 2, pp. 80-e1. Elsevier.

Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N, Gandaglia G, Eastham JA, Scardino PT, Vickers A and others (2017). “Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies.” European urology.

Assel M, Sjoberg DD and Vickers AJ (2017). “The Brier score does not evaluate the clinical utility of diagnostic tests or prediction models.” Diagnostic and Prognostic Research, 1(1), pp. 19.

Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE and others (2018). “Does subclassification of pathologically organ-confined (pT2) prostate cancer provide prognostic discrimination of outcomes after radical prostatectomy?” The Journal of urology.

Capogrosso P, Larcher A, Sjoberg DD, Vertosick EA, Cianflone F, Dell’Oglio P, Carenzi C, Salonia A, Vickers AJ, Montorsi F and others (2018). “Risk-based surveillance after surgical treatment of renal cell carcinoma.” The Journal of urology.

Sjoberg DD, Vickers AJ, Assel M, Dahlin A, Poon BY, Ulmert D and Lilja H (2018). “Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men.” European urology.

Dowling CM, Assel M, Musser JE, Meeks JJ, Sjoberg DD, Bosl G, Motzer R, Bajorin D, Feldman D, Carver BS and others (2018). “Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.” Urology.